Ginkgo Bioworks Holdings, Inc. (DNA) Recently Broke Out Above the 50-Day Moving Average

The bullish case only gets stronger once investors take into account DNA's positive earnings estimate revisions. There have been 1 higher compared to none lower for the current fiscal year, and the consensus estimate has moved up as well. With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on DNA for more gains in the near future. After reaching an important support level, Ginkgo Bioworks Holdings, Inc. (DNA) could be a good stock pick ...